Laquinimod suppress antigen presentation in relapsing–remitting multiple sclerosis: In-vitro high-throughput gene expression study - Gurevich, M.; Gritzman, T.; Orbach, R.; Tuller, T.; Feldman, A.; Achiron, A. (Journal of neuroimmunology, 2010)
Keywords: Adult; Allergy and Immunology; Antigen Presentation - drug effects; Antigens, CD - metabolism; Cell subpopulation; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Profiling - methods; Gene Expression Regulation - drug effects; Humans; Immunologic Factors - pharmacology; Killer Cells, Natural - drug effects; Laquinimod; Leukocytes, Mononuclear - drug effects; Leukocytes, Mononuclear - metabolism; Microarray gene expression; Middle Aged; Models, Immunological; Multiple sclerosis; Multiple Sclerosis, Relapsing-Remitting - immunology; Multiple Sclerosis, Relapsing-Remitting - pathology; Neurology; NF-kappaB-Inducing Kinase; Oligonucleotide Array Sequence Analysis - methods; PBMC; Protein Array Analysis - methods; Protein Serine-Threonine Kinases - metabolism; Quinolones - pharmacology; Microarray gene expression; Multiple sclerosis; Laquinimod; PBMC; Cell subpopulation